Study of R-3750 for mild to moderate COPD
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests an investigational drug called R-3750 in patients with mild to moderate COPD. It aims to see if the drug is safe and helps control symptoms. Eligible patients must have had COPD for at least a year, have mild to moderate airflow limitation, and have had at least one COPD flare-up in the past year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have COPD that was diagnosed by a doctor at least 1 year ago
- Your lung function tests show moderate breathing limitation (FEV1 between 50% and 80% of normal)
- You have had at least 1 COPD flare-up (exacerbation) in the last 12 months
- You are 40 years or older
- You have smoked a total of at least 10 pack-years (for example, 1 pack a day for 10 years)
- You have been on stable COPD medications (like inhalers) for at least 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.
This trial tests a new medicine, Hemay005, in adults with moderate to severe COPD who also have a chronic cough with mucus. It looks at how the drug affects certain markers in the body related to the disease.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
This trial tests a new bronchoscopy treatment for people with chronic obstructive pulmonary disease (COPD) who have had flare-ups. It aims to find if this treatment can help reduce symptoms and improve quality of life.
This trial tests a new drug (R-3750) given by mouth through a feeding tube for patients with severe lung injury (ARDS) that hasn't improved after one to four weeks of intensive care. The goal is to see if the drug helps patients recover better.
Hear when a new COPD Exacerbation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.